SQUIBB BRISTOL MYERS COMPANY has a total of 36 patent applications. It increased the IP activity by 130.0%. Its first patent ever was published in 2013. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are OHMEDA PHARMA PROD, RHONE POULENC RORER INT and UNIBIOS SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 36 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Dyckman Alaric J | 4 |
#2 | Macor John E | 3 |
#3 | Haque Tasir Shamsul | 3 |
#4 | Dodd Dharmpal S | 3 |
#5 | Posy Shoshana L | 3 |
#6 | Wurtz Nicholas R | 3 |
#7 | Dhar T G Murali | 2 |
#8 | Tortolani David R | 2 |
#9 | Selby Mark J | 2 |
#10 | Sistla Ramesh Kumar | 2 |
Publication | Filing date | Title |
---|---|---|
CN111527084A | Isofuranone compounds useful as HPK1 inhibitors | |
CN111051534A | Method for monitoring pharmacodynamic response mediated by glucocorticoid administration in vivo | |
CN110997656A | Substituted indole compounds useful as inhibitors of TLR7/8/9 | |
CN110914257A | Spiroheptyl hydantoins as ROCK inhibitors | |
CN110300803A | Improve the method in cellular genome with source orientation reparation (HDR) efficiency | |
CN110072860A | It can be used as the compound of immunomodulator | |
CN109923107A | The method for being used to prepare indole carboxamides compound |